Fuji Keizai: Japan Pharma Capex Up 50% to 946 Billion Yen
KEY POINTSFuji Keizai survey shows 25 Japanese drugmakers’ capital spending reaches 946 billion yen in 2025, about 50%…
Japan’s Asahi Kasei acquires license for novel ADC technology from Noguchi Institute
Japan’s Asahi Kasei acquires license for novel ADC technology from Noguchi Institute May 28, 2026 | Thursday |…